Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications
View through CrossRef
NUP98 fusions constitute a small subgroup of AML patients and remain a high-risk AML subtype. There are approximately 30 types of NUP98 fusions identified in AML patients. These patients show resistance to currently available therapies and poor clinical outcomes. NUP98 fusions with different fusion partners have oncogenic transformation potential. This review describes how the NUP98 gene acquires oncogenic properties after rearrangement with multiple partners. In the mechanistic part, the formation of nuclear bodies and dysregulation of the HoxA/Meis1 pathway are highlighted. This review also discusses mutational signatures among NUP98 fusions and their significance in leukemogenesis. It also discusses the clinical implications of NUP98 fusions and their associated mutations in AML patients. Furthermore, it highlights therapeutic vulnerabilities in these leukemias that can be exploited as therapeutic strategies. Lastly, this review discusses the gaps in our knowledge regarding NUP98 fusions in AML, as well as future research opportunities.
Title: NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications
Description:
NUP98 fusions constitute a small subgroup of AML patients and remain a high-risk AML subtype.
There are approximately 30 types of NUP98 fusions identified in AML patients.
These patients show resistance to currently available therapies and poor clinical outcomes.
NUP98 fusions with different fusion partners have oncogenic transformation potential.
This review describes how the NUP98 gene acquires oncogenic properties after rearrangement with multiple partners.
In the mechanistic part, the formation of nuclear bodies and dysregulation of the HoxA/Meis1 pathway are highlighted.
This review also discusses mutational signatures among NUP98 fusions and their significance in leukemogenesis.
It also discusses the clinical implications of NUP98 fusions and their associated mutations in AML patients.
Furthermore, it highlights therapeutic vulnerabilities in these leukemias that can be exploited as therapeutic strategies.
Lastly, this review discusses the gaps in our knowledge regarding NUP98 fusions in AML, as well as future research opportunities.
Related Results
Categorizing Molecular Mutations in MDS and AML
Categorizing Molecular Mutations in MDS and AML
Abstract
Introduction:
A huge amount of data on genetic alterations has been compiled by high throughput sequencing studies in several hematologic mal...
Clinical and Molecular Characteristics of NPM1MTDe Novo AML ( NPM1MT dnAML) Differ from NPM1MT therapy-associated AML ( NPM1MT tAML)
Clinical and Molecular Characteristics of NPM1MTDe Novo AML ( NPM1MT dnAML) Differ from NPM1MT therapy-associated AML ( NPM1MT tAML)
Background: NPM1-mutated AML accounts for 30% of all adult AML cases and frequently carries a favorable prognostic impact when enriched by a normal karyotype and the absence of FLT...
Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function
Down-Regulation of Signal Transducer and Activator of Transcription 3 Enhances Acute Myeloid Leukemia-Derived Dendritic Cell Function
Abstract
Abstract 3140
Immunotherapies, including stimulating patients' immune system with acute myeloid leukemia (AML)-derived dendritic cell (DC) va...
Low miR‐34c expression is associated with poor outcome in de novo acute myeloid leukemia
Low miR‐34c expression is associated with poor outcome in de novo acute myeloid leukemia
SummaryIntroductionMicroRNA‐34c (miR‐34c) has been found to play important roles in tumorigenesis. However, little is known about miR‐34c expression and the impact on prognosis in ...
NK-92 Preferentially Targets Acute Myeloid Leukemia Stem Cells
NK-92 Preferentially Targets Acute Myeloid Leukemia Stem Cells
Abstract
Abstract 4300
Introduction:
Outcome of patients with acute myeloid leukemia (AML) remains poor because m...
Early Occurrence of Therapy-Related Acute Myeloid Leukemia (t-AML) with Monocytic Differentiation with Trisomy 8 Cytogenetic Abnormality after Radioactive Iodine (RAI) Treatment for Papillary Thyroid Cancer
Early Occurrence of Therapy-Related Acute Myeloid Leukemia (t-AML) with Monocytic Differentiation with Trisomy 8 Cytogenetic Abnormality after Radioactive Iodine (RAI) Treatment for Papillary Thyroid Cancer
Abstract
Background: Although most t-AML occurs after chemotherapy +/- radiation, exposure to radioactive substances can be implicated, as in nuclear accidents. Thyr...
ΜΙSΤRG Mice Support Good-Risk AML Engraftment
ΜΙSΤRG Mice Support Good-Risk AML Engraftment
Abstract
Introduction
Acute myeloid leukemia (AML) is a hematopoietic stem cell derived disease with still unsatisfactory treatment options. Its broad...
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
Secondary acute myeloid leukemia (sAML) after myelodysplastic or myeloproliferative disorders is a high-risk category currently identified by clinical history or specific morpholog...